Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOXIRI for Neoadjuvant Treatment of High-risk Locally Advanced Colorectal Cancer
NCT05018182Phase 2Unknown
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2021
- Primary completion
- Apr 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin, irinotecan, folinic acid, fluorouracil in colorectal cancer (CRC), sponsored by West China Hospital of Sichuan University. Status: unknown.
02
Drugs
oxaliplatinirinotecanfolinic acidfluorouracil
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT05018182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05018182.